HER2-targeted therapy influences CTC status in metastatic breast cancer. Deutsch TM, Riethdorf S, Fremd C, Feisst M, et al. Breast Cancer Res Treat 2020 May 20. pii: 10.1007/s10549-020-05687.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Deutsch TM, Riethdorf S, Fremd C, Feisst M, et al. HER2-targeted therapy influences CTC status in metastatic breast cancer. Breast Cancer Res Treat 2020 May 20. pii: 10.1007/s10549-020-05687.
PMID: 32436146